Takuya Tsunoda
Career history of Takuya Tsunoda
Former positions of Takuya Tsunoda
Companies | Position | Start | End |
---|---|---|---|
City of Hope National Cancer Institute
City of Hope National Cancer Institute Hospital/Nursing ManagementHealth Services City of Hope is a research and treatment center for cancer, diabetes and various life-threatening diseases. The center is founded in 1913 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | 1994-01-31 | - |
Immunas Pharma, Inc.
Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Director/Board Member | 2013-05-31 | - |
President | 2013-05-31 | - | |
ONCOTHERAPY SCIENCE, INC. | Director/Board Member | 2006-03-31 | - |
Corporate Officer/Principal | 2006-03-31 | 2010-04-30 | |
President | 2010-04-30 | - |
Training of Takuya Tsunoda
Wakayama Medical University | Undergraduate Degree |
Statistics
International
Japan | 4 |
United States | 2 |
Operational
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
President | 2 |
Sectoral
Health Technology | 3 |
Health Services | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ONCOTHERAPY SCIENCE, INC. | Health Technology |
Private companies | 2 |
---|---|
City of Hope National Cancer Institute
City of Hope National Cancer Institute Hospital/Nursing ManagementHealth Services City of Hope is a research and treatment center for cancer, diabetes and various life-threatening diseases. The center is founded in 1913 and is headquartered in Los Angeles, CA. | Health Services |
Immunas Pharma, Inc.
Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Health Technology |
- Stock Market
- Insiders
- Takuya Tsunoda
- Experience